A Rare Case of Mucormycosis in the Scalp
Introduction: Mucormycosis is a rapidly progressive and frequently lethal form of fungal infection. Primary cutaneous form is rare. We presented a case of cutaneous mucormycosis in the scalp which led to visual loss in a 54-year-old diabetic woman.
Case Presentation: A 54-year-old woman patient was admitted with the complaining of the wound with purulent discharge in the scalp. An ulcerated discharging lesion with necrotic hemorrhagic crusts in the left parietal region of the scalp and wheals with fluctuating from this lesion to the left periorbital area were observed. Biochemical investigations revealed elevated blood sugar level and urine ketone bodies were present. The patient had vision loss in the left eye. In the smears thick-walled non-septate hyphae were detected. Rhizopus spp. was isolated from culture. Antidiabetic therapy and liposomal amphotericin B was initiated. The scalp lesion improved.
Conclusion: Early diagnosis is life saving in mucormycosis.
How to Cite
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.